What to know A Viagra-like drug, Mvix, showed promise in slowing Alzheimer's in patients not on other dementia drugs, according to a global trial. The study found a 30% reduction in mental decline for these patients. AriBio, the drug's developer, plans to discuss the results with the FDA. The drug's effects were less pronounced in patients already on dementia medications. Summary is AI-generated, newsroom-reviewed. |